I understand the TLX CEO was asked a direct question about CU6 but I’m not sure why so many put any credence into the CEO’s response.
Can you imagine what would happen to TLX’s share price if the CEO said oh yes CU6 can detect much smaller lesions than we can. The FDA doesn’t fast track for no reason it’s definitely cutting edge…
Of course if he did the price of TLX would be cut in half. No matter how good a competitor is no CEO will ever come out and say they’re better if they did they wouldn’t have a job next week.
Its just common sense.
Anyway it’s stupid comparing the 2 companies at different stages in their lives.
Good luck to holders of both companies.
I understand the TLX CEO was asked a direct question about CU6...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.12 |
Change
0.400(5.95%) |
Mkt cap ! $2.245B | |||
| Open | High | Low | Value | Volume |
| $6.88 | $7.45 | $6.82 | $14.30M | 1.996M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21806 | $7.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.14 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |